October 01, 2025 a 07:43 am
WST: Fundamental Ratio Analysis - West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc., with a strong presence in healthcare product manufacturing, shows promising growth potential supported by consistent innovation. Its diversified segments allow it to tackle various needs in the pharmaceutical industry, reflected in its solid market performance.
Fundamental Rating
West Pharmaceutical Services holds a commendable rating, indicating a stable financial foundation. Below are key metrics and their corresponding evaluation:
| Metric | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 3 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
The historical scores provide insight into the company's financial trends and stability over time:
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-09-30 | 3 | 4 | 4 | 5 | 3 | 1 | 1 |
| Previous | 0 | 4 | 4 | 5 | 3 | 1 | 1 |
Analyst Price Targets
Analyst projections reflect confidence in an upward price trajectory with a consensus to buy:
| High | Low | Median | Consensus |
|---|---|---|---|
| $311 | $245 | $278 | Buy |
A visual representation of past stock movements, giving context to analyst predictions.
Analyst Ratings
Current analyst recommendations lean strongly towards a buy position:
| Type | Number | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 10 | |
| Hold | 2 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
West Pharmaceutical Services, Inc. represents a robust investment opportunity within the healthcare sector. Positive fundamental ratings and favorable analyst projections support its growth potential. However, potential investors should remain mindful of market fluctuations and industry risks that could impact performance. Overall, its innovative solutions and strong industry position offer a promising outlook.